Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Merck shares positive phase 3 results for pulmonary arterial hypertension therapy

The progressive blood vessel disorder affects approximately 40,000 people in the US

- PMLiVE

Enabling a sustainable and mutually beneficial CDMO partnership

There are a multitude of CDMO options available, all providing specialised expertise and solutions for diverse and complex activities

- PMLiVE

UK researchers uncover first new asthma and COPD attack treatment in 50 years

The phase 2 study showed that benralizumab could be re-purposed for use in emergency settings

- PMLiVE

GSK granted EC approval for meningococcal disease vaccine Menveo

The fully liquid presentation is designed to simplify the vaccination process

- PMLiVE

Galderma announces positive late-stage results for nemolizumab in prurigo nodularis

The chronic skin condition is estimated to affect up to 181,000 people in the US

- PMLiVE

Seven strategic steps to enhance patient recruitment & retention in your influenza studies

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

Innovative Trials

- PMLiVE

Health equity: what will you do?

Achieving health equity is a multidimensional challenge

- PMLiVE

AstraZeneca announces positive results for Truqap in phase 3 prostate cancer study

More than 52,000 cases of prostate cancer are diagnosed in the UK every year

- PMLiVE

BeiGene’s Tevimbra approved by EC for first-line gastric and oesophageal cancer use

Gastric cancer is the fifth leading cause of cancer-related deaths globally and oesophageal cancer is the sixth

- PMLiVE

Sanofi opens €558m modular concept manufacturing facility in Singapore

The facility is designed to enable rapid changes in production capacities across medicines

- PMLiVE

How the ‘five Ps’ can close health equity gaps

Policymakers, payers, providers, patients and pharma are each uniquely able to impact health equity – and together, achieve real progress

- PMLiVE

Novartis’ Kisqali receives EC approval to treat early breast cancer patients

Approximately 70% of breast cancer cases are diagnosed in the early stages of the disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links